A novel concentrated growth factor (CGF)-based strategy for second molar protection after impacted mandibular third molar extraction: a randomized controlled clinical study

Author:

Sun Shoufu F.1,Xu Xiaodong D.1,Zhang Zhongxiao X.2,Zhang Ying1,Wei Wenjia J.1,Jiang Yunan N.1,Guo K.1

Affiliation:

1. Shanghai Jiao Tong University School of Medicine

2. Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine

Abstract

Abstract Background:The extraction of impacted mandibular third molars might cause large bone defects in the distal area of second molars. A new strategy was innovatively employed here combining autologous bone, Bio-Oss, concentrated growth factors (CGF) gel and CGF membrane for bone repair, and the present study aimed at exploring safety as well as short- and long-term efficacy of this new protocol clinically. Materials and methods: A total of 66 participants were enrolled in this randomized single-blind clinical trial, and randomly allocated to control group (only blood clots), test A group (autogenous bone,Bio-Oss with oral repair membrane) and test B group (autogenous bone,Bio-Oss, CGF gel with CGF membrane). The postoperative outcomes including PoSSe scale, periodontal probing depth (PD), degree of gingival recession and computed tomography measurements were assessed at 3th, 6th, 12th month. A p-value<0.05 was considered statistically significant. Results: In PoSSe scale, no significant difference was observed except a significant alleviation of early-stage pain perception in test B group (p<0.05). Also, test B group exhibited better effect on periodontal healing and gingival recession reduction after 6 months (p<0.05). Both two test groups showed more new bone formation than the control group (p<0.05). It is noteworthy that the bone repair of test B group was significantly better than that of test A at 3th and 6th month (p<0.05), yet no difference was observed at 12th month (p>0.05). Conclusion: Both two test groups could achieve stable long-term efficacy on alveolar bone repair. The use of CGF gel and CGF membrane could accelerate early-stage bone repair, alleviate short-term pain after surgery, reduce long-term probing depth and relieve economic cost for patients. This new bone repair protocol is worthy of promoting by clinicians. Trial registration: This study was registered with the identification number ChiCTR2300068466 on 20/02/2023 at Chinese Clinical Trial Registry. Also, it was ethically approved from the institutional ethics committee at the Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (No:2023-010-01), and has been conducted in accordance to the guidelines of the declaration of Helsinki. Written informed consent was obtained from all participants in the study.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3